Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pesticides | 6 | 2024 | 294 | 3.700 |
Why?
|
Breast Neoplasms | 44 | 2024 | 20985 | 2.800 |
Why?
|
Oxidative Stress | 33 | 2024 | 3108 | 2.530 |
Why?
|
Nitric Oxide | 26 | 2024 | 2133 | 1.450 |
Why?
|
Glutathione Transferase | 2 | 2021 | 565 | 1.240 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2020 | 288 | 1.210 |
Why?
|
Oxidation-Reduction | 11 | 2024 | 2227 | 1.020 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2019 | 128 | 0.990 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2021 | 1085 | 0.970 |
Why?
|
Brazil | 8 | 2024 | 1224 | 0.950 |
Why?
|
Occupational Exposure | 3 | 2024 | 1811 | 0.930 |
Why?
|
Receptor, erbB-2 | 7 | 2022 | 2553 | 0.890 |
Why?
|
Agriculture | 1 | 2024 | 190 | 0.840 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2020 | 512 | 0.830 |
Why?
|
Chagas Disease | 3 | 2020 | 167 | 0.830 |
Why?
|
Atrazine | 1 | 2022 | 9 | 0.830 |
Why?
|
Pesticide Residues | 1 | 2023 | 95 | 0.800 |
Why?
|
Agricultural Workers' Diseases | 1 | 2022 | 28 | 0.800 |
Why?
|
Antioxidants | 9 | 2022 | 1670 | 0.790 |
Why?
|
Proteomics | 9 | 2019 | 3818 | 0.790 |
Why?
|
Reactive Oxygen Species | 12 | 2024 | 2137 | 0.740 |
Why?
|
Leishmania | 5 | 2021 | 75 | 0.730 |
Why?
|
Lipid Peroxidation | 15 | 2022 | 271 | 0.720 |
Why?
|
Doxorubicin | 5 | 2021 | 2215 | 0.700 |
Why?
|
Antiprotozoal Agents | 5 | 2019 | 94 | 0.700 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 1089 | 0.700 |
Why?
|
Plant Leaves | 1 | 2020 | 150 | 0.680 |
Why?
|
Trypanosoma cruzi | 6 | 2020 | 206 | 0.680 |
Why?
|
Inflammation Mediators | 5 | 2024 | 1886 | 0.680 |
Why?
|
NF-kappa B | 5 | 2024 | 2485 | 0.680 |
Why?
|
Paclitaxel | 5 | 2021 | 1732 | 0.670 |
Why?
|
Neoplasms | 10 | 2023 | 22083 | 0.620 |
Why?
|
Hospital Records | 1 | 2018 | 93 | 0.600 |
Why?
|
Cytokines | 13 | 2023 | 7377 | 0.580 |
Why?
|
Interleukin-12 | 4 | 2023 | 583 | 0.570 |
Why?
|
Mass Spectrometry | 5 | 2016 | 2189 | 0.560 |
Why?
|
Peroxidase | 1 | 2020 | 610 | 0.550 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2017 | 621 | 0.550 |
Why?
|
Macrophages, Peritoneal | 5 | 2020 | 236 | 0.540 |
Why?
|
Leishmaniasis, Cutaneous | 4 | 2021 | 136 | 0.540 |
Why?
|
Caffeine | 1 | 2020 | 700 | 0.520 |
Why?
|
Autoimmunity | 2 | 2020 | 1355 | 0.490 |
Why?
|
Lipid Peroxides | 4 | 2023 | 74 | 0.480 |
Why?
|
Pain, Intractable | 1 | 2015 | 132 | 0.480 |
Why?
|
Glutathione | 5 | 2024 | 582 | 0.470 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 250 | 0.470 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 203 | 0.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2023 | 8519 | 0.450 |
Why?
|
Prognosis | 16 | 2023 | 29551 | 0.440 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1790 | 0.440 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 532 | 0.420 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3874 | 0.400 |
Why?
|
Propolis | 3 | 2016 | 13 | 0.400 |
Why?
|
Female | 69 | 2024 | 391875 | 0.390 |
Why?
|
Adiponectin | 2 | 2014 | 1113 | 0.370 |
Why?
|
Down-Regulation | 3 | 2020 | 2911 | 0.360 |
Why?
|
Metformin | 4 | 2020 | 905 | 0.350 |
Why?
|
Proteome | 3 | 2015 | 1861 | 0.350 |
Why?
|
Chagas Cardiomyopathy | 1 | 2010 | 71 | 0.340 |
Why?
|
Concanavalin A | 2 | 2020 | 190 | 0.340 |
Why?
|
Transforming Growth Factor beta | 3 | 2015 | 1959 | 0.340 |
Why?
|
Humans | 78 | 2024 | 760437 | 0.340 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5292 | 0.330 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1899 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2024 | 4355 | 0.330 |
Why?
|
Environmental Exposure | 1 | 2024 | 4443 | 0.320 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 985 | 0.320 |
Why?
|
Leukotrienes | 1 | 2010 | 231 | 0.320 |
Why?
|
Leishmania braziliensis | 2 | 2019 | 16 | 0.310 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5143 | 0.310 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13616 | 0.300 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2020 | 613 | 0.300 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1807 | 0.290 |
Why?
|
Protein Carbonylation | 4 | 2015 | 28 | 0.290 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 916 | 0.290 |
Why?
|
Neutrophils | 1 | 2020 | 3764 | 0.280 |
Why?
|
Leishmaniasis | 2 | 2017 | 66 | 0.280 |
Why?
|
Chromatography, Liquid | 3 | 2015 | 983 | 0.280 |
Why?
|
Breast | 1 | 2015 | 1962 | 0.270 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.270 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 16945 | 0.270 |
Why?
|
DNA Damage | 3 | 2017 | 2441 | 0.260 |
Why?
|
Middle Aged | 35 | 2024 | 220382 | 0.250 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3792 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2297 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2821 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9267 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17854 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 3800 | 0.240 |
Why?
|
Malondialdehyde | 5 | 2015 | 112 | 0.240 |
Why?
|
Ruthenium Compounds | 2 | 2016 | 8 | 0.240 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4879 | 0.240 |
Why?
|
Inflammation | 10 | 2024 | 10746 | 0.230 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 3610 | 0.230 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 374 | 0.220 |
Why?
|
Hematocrit | 1 | 2005 | 625 | 0.220 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 677 | 0.220 |
Why?
|
Neoplasm Staging | 8 | 2023 | 11096 | 0.220 |
Why?
|
Erythrocytes | 5 | 2015 | 2417 | 0.220 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 61 | 0.220 |
Why?
|
Wedelia | 1 | 2022 | 1 | 0.210 |
Why?
|
Arthritis, Gouty | 1 | 2022 | 28 | 0.210 |
Why?
|
Rats, Wistar | 8 | 2022 | 1844 | 0.210 |
Why?
|
Aldrin | 1 | 2022 | 2 | 0.210 |
Why?
|
Trifluralin | 1 | 2022 | 2 | 0.210 |
Why?
|
Diuron | 1 | 2022 | 4 | 0.210 |
Why?
|
Chlordan | 1 | 2022 | 5 | 0.210 |
Why?
|
Dieldrin | 1 | 2022 | 7 | 0.210 |
Why?
|
Interleukin-4 | 2 | 2023 | 1130 | 0.210 |
Why?
|
DDT | 1 | 2022 | 31 | 0.210 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 70 | 0.210 |
Why?
|
Signal Transduction | 12 | 2024 | 23397 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2023 | 10425 | 0.200 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3782 | 0.200 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6206 | 0.200 |
Why?
|
Rural Population | 2 | 2024 | 2279 | 0.200 |
Why?
|
Adult | 30 | 2024 | 220781 | 0.200 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 85 | 0.200 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4319 | 0.200 |
Why?
|
Animals | 34 | 2023 | 168253 | 0.190 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13312 | 0.190 |
Why?
|
Chalcone | 1 | 2020 | 10 | 0.180 |
Why?
|
Chalcones | 1 | 2020 | 30 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1841 | 0.180 |
Why?
|
Aged | 19 | 2024 | 168840 | 0.180 |
Why?
|
Medulla Oblongata | 1 | 2022 | 248 | 0.180 |
Why?
|
Research Report | 1 | 2023 | 367 | 0.170 |
Why?
|
Halogenation | 1 | 2020 | 48 | 0.170 |
Why?
|
Glutathione S-Transferase pi | 1 | 2020 | 99 | 0.170 |
Why?
|
DNA Modification Methylases | 1 | 2021 | 210 | 0.170 |
Why?
|
Perioperative Period | 1 | 2021 | 249 | 0.170 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 870 | 0.170 |
Why?
|
Carcinoma | 1 | 2011 | 2328 | 0.170 |
Why?
|
Stress, Psychological | 1 | 2015 | 4475 | 0.170 |
Why?
|
Case-Control Studies | 8 | 2024 | 22097 | 0.170 |
Why?
|
Diterpenes | 2 | 2022 | 171 | 0.170 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.170 |
Why?
|
Obesity | 4 | 2017 | 12918 | 0.160 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2805 | 0.160 |
Why?
|
Hypertension | 5 | 2022 | 8527 | 0.160 |
Why?
|
Triclosan | 1 | 2019 | 58 | 0.160 |
Why?
|
Leishmania mexicana | 2 | 2015 | 33 | 0.160 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2016 | 555 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 2 | 2024 | 3396 | 0.160 |
Why?
|
Proteins | 1 | 2014 | 6033 | 0.160 |
Why?
|
Sodium Glutamate | 3 | 2017 | 23 | 0.160 |
Why?
|
Quercetin | 1 | 2019 | 97 | 0.160 |
Why?
|
Ascorbic Acid | 1 | 2022 | 655 | 0.160 |
Why?
|
Survival Analysis | 3 | 2024 | 10075 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 370 | 0.150 |
Why?
|
HIV-1 | 2 | 2015 | 6859 | 0.150 |
Why?
|
Apoptosis | 8 | 2023 | 9468 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2022 | 675 | 0.150 |
Why?
|
Axilla | 1 | 2020 | 624 | 0.140 |
Why?
|
Blotting, Western | 2 | 2015 | 5031 | 0.140 |
Why?
|
Melatonin | 1 | 2023 | 669 | 0.140 |
Why?
|
Superoxide Dismutase | 3 | 2022 | 592 | 0.140 |
Why?
|
Monoterpenes | 1 | 2017 | 22 | 0.140 |
Why?
|
1,2-Dimethylhydrazine | 1 | 2016 | 8 | 0.140 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 225 | 0.140 |
Why?
|
Cell Polarity | 1 | 2020 | 637 | 0.140 |
Why?
|
Silver | 1 | 2017 | 117 | 0.140 |
Why?
|
Aberrant Crypt Foci | 1 | 2016 | 12 | 0.140 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 247 | 0.140 |
Why?
|
Tyrosine | 2 | 2024 | 1438 | 0.140 |
Why?
|
Nitroso Compounds | 1 | 2016 | 71 | 0.140 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3183 | 0.140 |
Why?
|
Bone Marrow Cells | 1 | 2024 | 2416 | 0.130 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 518 | 0.130 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2015 | 2 | 0.130 |
Why?
|
Guanidines | 1 | 2017 | 192 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3587 | 0.130 |
Why?
|
Trypanocidal Agents | 1 | 2016 | 41 | 0.130 |
Why?
|
Nitrates | 2 | 2015 | 263 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2013 | 2163 | 0.130 |
Why?
|
Nitroprusside | 1 | 2016 | 272 | 0.130 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11070 | 0.130 |
Why?
|
Gout | 1 | 2022 | 623 | 0.130 |
Why?
|
Uterus | 1 | 2019 | 649 | 0.120 |
Why?
|
beta Catenin | 1 | 2020 | 1040 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11095 | 0.120 |
Why?
|
Fetal Growth Retardation | 1 | 2019 | 579 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 733 | 0.120 |
Why?
|
Genomics | 2 | 2022 | 5806 | 0.120 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 98 | 0.120 |
Why?
|
Nitric Oxide Donors | 1 | 2015 | 124 | 0.120 |
Why?
|
Interleukin-1beta | 3 | 2015 | 997 | 0.120 |
Why?
|
Catalase | 2 | 2014 | 217 | 0.120 |
Why?
|
Myoblasts, Cardiac | 1 | 2014 | 21 | 0.120 |
Why?
|
Carcinoma, Ductal | 1 | 2015 | 97 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2911 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 1540 | 0.120 |
Why?
|
Mice | 17 | 2023 | 81402 | 0.120 |
Why?
|
Cyclooxygenase 1 | 1 | 2014 | 97 | 0.120 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9003 | 0.120 |
Why?
|
Cyclooxygenase 2 | 2 | 2014 | 597 | 0.120 |
Why?
|
Disease Progression | 3 | 2021 | 13484 | 0.120 |
Why?
|
Indomethacin | 1 | 2015 | 326 | 0.120 |
Why?
|
Vitamin D | 2 | 2020 | 3303 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 907 | 0.120 |
Why?
|
Ferritins | 2 | 2015 | 597 | 0.110 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 559 | 0.110 |
Why?
|
Enzyme Inhibitors | 4 | 2021 | 3710 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9410 | 0.110 |
Why?
|
Acute Disease | 2 | 2017 | 7230 | 0.110 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 254 | 0.110 |
Why?
|
Statistics, Nonparametric | 3 | 2013 | 2852 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 396 | 0.110 |
Why?
|
Albumins | 1 | 2016 | 575 | 0.110 |
Why?
|
Glycerol | 1 | 2014 | 274 | 0.110 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 629 | 0.110 |
Why?
|
Homocysteine | 1 | 2015 | 638 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2019 | 1058 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 503 | 0.100 |
Why?
|
Immunomodulation | 2 | 2016 | 547 | 0.100 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.100 |
Why?
|
Rats | 9 | 2022 | 23712 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 286 | 0.100 |
Why?
|
Oxidants | 1 | 2012 | 169 | 0.100 |
Why?
|
Transcription Factor RelA | 2 | 2024 | 253 | 0.100 |
Why?
|
Glycosylation | 1 | 2014 | 1097 | 0.100 |
Why?
|
Paracoccidioidomycosis | 1 | 2011 | 10 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1633 | 0.100 |
Why?
|
Male | 26 | 2024 | 360035 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2723 | 0.090 |
Why?
|
HIV Infections | 2 | 2015 | 17328 | 0.090 |
Why?
|
Iron | 3 | 2019 | 1787 | 0.090 |
Why?
|
Nitrites | 1 | 2011 | 159 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 787 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15867 | 0.090 |
Why?
|
Heart Rate | 5 | 2022 | 4190 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6813 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11729 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1900 | 0.090 |
Why?
|
Skin | 2 | 2016 | 4474 | 0.090 |
Why?
|
Cell Movement | 2 | 2020 | 5198 | 0.090 |
Why?
|
Mice, Knockout | 2 | 2019 | 14397 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2870 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15476 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2018 | 3157 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3631 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1341 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 934 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1037 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 321 | 0.080 |
Why?
|
Th2 Cells | 1 | 2013 | 1054 | 0.080 |
Why?
|
Prospective Studies | 3 | 2021 | 54339 | 0.080 |
Why?
|
Risk Factors | 4 | 2024 | 74055 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2014 | 3088 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3571 | 0.070 |
Why?
|
Heart Diseases | 1 | 2021 | 2785 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 685 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1032 | 0.070 |
Why?
|
Parasitemia | 2 | 2020 | 165 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2502 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4383 | 0.070 |
Why?
|
Endotoxemia | 1 | 2007 | 196 | 0.070 |
Why?
|
Homeostasis | 2 | 2015 | 3320 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 973 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2011 | 751 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4649 | 0.070 |
Why?
|
Cell Survival | 4 | 2017 | 5790 | 0.060 |
Why?
|
Aspirin | 2 | 2014 | 3134 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2023 | 2453 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5424 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 12976 | 0.060 |
Why?
|
Diet | 1 | 2023 | 8058 | 0.060 |
Why?
|
Osmotic Pressure | 1 | 2005 | 139 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 408 | 0.060 |
Why?
|
Myocardium | 3 | 2017 | 4700 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2007 | 906 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 701 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7996 | 0.060 |
Why?
|
Blood Pressure | 4 | 2022 | 8479 | 0.060 |
Why?
|
gamma-Glutamyltransferase | 2 | 2015 | 144 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2412 | 0.060 |
Why?
|
Autophagy | 2 | 2022 | 1319 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2525 | 0.050 |
Why?
|
Cohort Studies | 3 | 2015 | 41366 | 0.050 |
Why?
|
Cell Size | 1 | 2005 | 624 | 0.050 |
Why?
|
Postmenopause | 1 | 2012 | 2513 | 0.050 |
Why?
|
Macrophages | 4 | 2021 | 5764 | 0.050 |
Why?
|
Disabled Persons | 1 | 2012 | 1224 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4936 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6471 | 0.050 |
Why?
|
Thiohydantoins | 1 | 2022 | 19 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 404 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2907 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6230 | 0.050 |
Why?
|
Fishes | 1 | 2005 | 602 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4430 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2519 | 0.050 |
Why?
|
Receptors, Estrogen | 3 | 2015 | 2204 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 23953 | 0.050 |
Why?
|
Arginase | 1 | 2021 | 80 | 0.050 |
Why?
|
Dinoprostone | 2 | 2017 | 597 | 0.050 |
Why?
|
Sheep | 1 | 2023 | 1440 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 12932 | 0.050 |
Why?
|
Up-Regulation | 2 | 2020 | 4116 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2021 | 467 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4391 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9309 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3024 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 526 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2860 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15257 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 59068 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 18955 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2021 | 441 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21322 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 451 | 0.040 |
Why?
|
Estrous Cycle | 1 | 2019 | 65 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18216 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3956 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 586 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2021 | 927 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5704 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1054 | 0.040 |
Why?
|
Leukapheresis | 1 | 2018 | 134 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4518 | 0.040 |
Why?
|
Liver | 4 | 2015 | 7531 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 581 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2710 | 0.040 |
Why?
|
Uric Acid | 2 | 2014 | 808 | 0.030 |
Why?
|
Lactation | 1 | 2019 | 397 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16585 | 0.030 |
Why?
|
Phagocytes | 1 | 2018 | 296 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6894 | 0.030 |
Why?
|
Nitrosation | 1 | 2016 | 25 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 365 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58859 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2019 | 404 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2023 | 1400 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30025 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3685 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 145 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 671 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2019 | 920 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2015 | 412 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2022 | 835 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 2014 | 135 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 417 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22121 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2014 | 157 | 0.030 |
Why?
|
Anemia | 2 | 2015 | 1508 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39947 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 260 | 0.030 |
Why?
|
Fetal Development | 1 | 2019 | 769 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2015 | 297 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1176 | 0.030 |
Why?
|
Hindlimb | 1 | 2015 | 509 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 597 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 606 | 0.030 |
Why?
|
Dinoprost | 1 | 2013 | 138 | 0.030 |
Why?
|
Sulfonamides | 2 | 2014 | 1973 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1588 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1559 | 0.030 |
Why?
|
Lung | 3 | 2022 | 9973 | 0.030 |
Why?
|
Luminescence | 1 | 2012 | 108 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2015 | 649 | 0.020 |
Why?
|
Mediator Complex | 1 | 2012 | 106 | 0.020 |
Why?
|
Pyrazoles | 2 | 2014 | 2007 | 0.020 |
Why?
|
Paracoccidioides | 1 | 2011 | 3 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3822 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12054 | 0.020 |
Why?
|
Rodent Diseases | 1 | 2011 | 53 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 1228 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3446 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1610 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13240 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1755 | 0.020 |
Why?
|
X-Rays | 1 | 2011 | 306 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 704 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1536 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3592 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 330 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2011 | 698 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1887 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5778 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4903 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 756 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26063 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1509 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3742 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1337 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 728 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2929 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1349 | 0.020 |
Why?
|
Blood | 1 | 2010 | 584 | 0.020 |
Why?
|
Hemoglobins | 1 | 2014 | 1524 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10494 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5078 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5075 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39078 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1128 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2007 | 174 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4010 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5794 | 0.020 |
Why?
|
Collagen | 1 | 2015 | 2637 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1897 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1370 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
Swimming | 1 | 2007 | 208 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1384 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6297 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1834 | 0.020 |
Why?
|
Fibroblasts | 1 | 2015 | 4106 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2272 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2799 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2423 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10698 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 64591 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8623 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2252 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1874 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3059 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10759 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12969 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15598 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12698 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2205 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5663 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6380 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10538 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6591 | 0.010 |
Why?
|
Public Health | 1 | 2011 | 2665 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3306 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29831 | 0.010 |
Why?
|
Body Weight | 1 | 2007 | 4614 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 80430 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18379 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5662 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15820 | 0.010 |
Why?
|